Edwards Lifesciences Buy or Sell Recommendation

Macroaxis provides Edwards Lifesciences Corporation buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Edwards Lifesciences positions. The advice algorithm takes into account all of Edwards Lifesciences Corporation available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Edwards Lifesciences buy-and-hold prospective. Additionally see Edwards Lifesciences Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with current analyst consensus

Investment Horizon


Risk Tolerance

Execute Advice
Edwards Lifesciences Corporation -- USA Stock  

USD 110.05  1.53  1.41%

Allowing for the 30-days total investment horizon, and your above average risk tolerance our recommendation regarding Edwards Lifesciences Corporation is 'Strong Hold'.
For the selected time horizon Edwards Lifesciences Corporation has a risk adjusted performance of (0.016888), jensen alpha of (0.23), total risk alpha of (0.64), sortino ratio of 0.0 and treynor ratio of (0.12)
Macroaxis provides buy, hold, or sell suggestion on Edwards Lifesciences to complement and cross-verify current analyst consensus on Edwards Lifesciences Corporation. Our buy, hold, or sell recommendation engine determines the organization potential to grow exclusively from the prospective of investors current risk tolerance and investing horizon. To make sure Edwards Lifesciences is not overpriced, please confirm all Edwards Lifesciences fundamentals including its Book Value Per Share, and the relationship between Cash and Equivalents and Number of Employees . Given that Edwards Lifesciences has Price to Sales of 7.28 times, we urge you verify Edwards Lifesciences Corporation market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Returns Distribution Density

Mean Return-0.1Value At Risk-1.6001
Potential Upside1.4099Standard Deviation0.9635
 Return Density 

Institutional Investors

Security TypeSharesValue
Factory Mutual Insurance CoCommon Shares191.3 K20.9 M
Nisa Investment Advisors LlcCommon Shares102 K11.2 M
Btim CorpCommon Shares94.2 K10.3 M
Rhenman Partners Asset Management AbCommon Shares80 K8.7 M
Gulf International Bank Uk LtdCommon Shares65.9 K7.2 M
First American BankCommon Shares62.3 K6.8 M
Patten Patten IncCommon Shares62 K6.8 M

Edwards Lifesciences Greeks

Alpha over DOW
βBeta against DOW= 0.91 
Overall volatility
= 0.96 
 IrInformation ratio =(0.25) 

Edwards Lifesciences Volatility Alert

Edwards Lifesciences Corporation exhibits very low volatility with skewness of 0.08 and kurtosis of -0.4. However, we advise investors to further study Edwards Lifesciences Corporation technical indicators to make sure all market info is available and is reliable.
 Better Than Average     
 Worse Than Average Compare Edwards Lifesciences to competition
FundamentalsEdwards LifesciencesPeer Average
Return On Equity26.47 % (15.17) %
Return On Asset13.17 % (15.64) %
Current Valuation22.97 B152.14 B
Shares Outstanding211.16 M1.43 B
Shares Owned by Insiders5.19 % 6.91 %
Number of Shares Shorted1.66 M3.24 M
Price to Earning33.81 times40.69 times
Price to Book7.91 times14.44 times
Price to Sales7.28 times17.81 times
Revenue3.23 B9.85 B
Gross Profit2.17 B21.75 B
EBITDA1.05 B1.41 B
Net Income716.2 M517.71 M
Cash and Equivalents1.13 B3.89 B
Cash per Share5.36 times5.17 times
Total Debt1.02 B7.36 B
Debt to Equity34.5 times0.72 times
Current Ratio4.06 times3.3 times
Book Value Per Share13.93 times13.64 times
Cash Flow from Operations733 M1.25 B
Short Ratio1.54 times2.09 times
Earnings Per Share4.18 times2.3 times
Price to Earnings To Growth1.78 times1.22 times
Number of Employees9.8 K10.67 K
Market Capitalization23.54 B29.78 B
Total Asset4.06 B126.86 B
Retained Earnings3.91 B38.24 B
Working Capital1.57 B3.58 B
Current Asset2.05 B36.8 B
Current Liabilities476.2 M33.34 B
Z Score13.8708.73
Strong Hold


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

   Sale by Huimin Wang of 13700 shares of Edwards Lifesciences [view details]
Risk Adjusted Performance(0.016888)
Market Risk Adjusted Performance(0.11)
Mean Deviation0.746
Coefficient Of Variation(933.07)
Standard Deviation0.9635
Information Ratio(0.25)
Jensen Alpha(0.23)
Total Risk Alpha(0.64)
Treynor Ratio(0.12)
Maximum Drawdown3.61
Value At Risk(1.6)
Potential Upside1.41

Current Valuation

Edwards Lifesciences Current Valuation Analysis
Edwards Lifesciences Corporation is rated below average in current valuation category among related companies. After adjusting for long-term liabilities, total market size of Healthcare Products industry is currently estimated at about 223.28 Billion. Edwards Lifesciences retains roughly 22.97 Billion in current valuation claiming about 10% of equities under Healthcare Products industry.